GlassScriptPhysician profile
Angela Tang
NPI 1487108098
$1,567.81
in general payments reported to CMS, 2019-2025
20 companies · $28.56 in 2025
The $28.56 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $152 · 2021: $565 · 2022: $520 · 2023: $271 · 2024: $31.19 · 2025: $28.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $331.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $331.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $450.06 | 2020-2023 | Injectafer |
| Abbvie INC. | $301.92 | 2020-2023 | Orilissa, Lo Loestrin Fe |
| Astellas Pharma US INC | $131.80 | 2022-2025 | Veozah, Myrbetriq |
| Therapeuticsmd, INC. | $121.77 | 2020-2022 | |
| Organon LLC | $113.61 | 2021-2023 | Nexplanon |
| Urovant Sciences INC | $106.05 | 2021-2022 | |
| Pfizer INC. | $64.34 | 2022-2024 | |
| Myovant Sciences INC. | $49.35 | 2022 | |
| Merck Sharp & Dohme LLC | $35.85 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $32.01 | 2021-2023 | |
| Livanova USA, INC. | $21.37 | 2022 | |
| Minerva Surgical, INC | $20.09 | 2021 | |
| Mayne Pharma Commercial LLC | $19.41 | 2023 | |
| Agile Therapeutics, INC. | $17.83 | 2021 | |
| Axonics, INC. | $16.29 | 2023 | Axonics |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $15.96 | 2023 | Accrufer |
| Exeltis, USA INC. | $15.91 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.29 | 2021 | |
| Aspira Women'S Health INC | $13.38 | 2021 | |
| Alydia Health | $6.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Tang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.